BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monaghan P, Kyriacou A, Sturgeon C, Davies A, Trainer P, White A, Higham C. Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study. Clin Endocrinol 2016;85:569-74. [DOI: 10.1111/cen.13118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Gevers EF, Meredith S, Shah P, Torpiano J, Peters C, Sebire NJ, Slater O, White A, Dattani MT. Cushing syndrome in a child due to pro-opiomelanocortin (POMC) secretion from a yolk sac tumor. Eur J Endocrinol 2017;176:K1-7. [PMID: 27879325 DOI: 10.1530/EJE-16-0776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Harno E, Gali Ramamoorthy T, Coll AP, White A. POMC: The Physiological Power of Hormone Processing. Physiol Rev 2018;98:2381-430. [PMID: 30156493 DOI: 10.1152/physrev.00024.2017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
3 Schlegel A. Identifying Glucocorticoid Insufficiency in Silent Corticotroph Adenoma with Elevated Adrenocorticotropic Hormone. Lab Med 2021:lmab053. [PMID: 34270735 DOI: 10.1093/labmed/lmab053] [Reference Citation Analysis]
4 Mehta R, Lam-Chung CE, Hinojosa-Amaya JM, Roldán-Sarmiento P, Guillen-Placencia MF, Villanueva-Rodriguez G, Juarez-Leon OA, Leon-Domínguez J, Grajales-Gómez M, Ventura-Gallegos JL, León-Suárez A, Gómez-Pérez FJ, Cuevas-Ramos D. High Molecular Weight ACTH-Precursor Presence in a Metastatic Pancreatic Neuroendocrine Tumor Causing Severe Ectopic Cushing's Syndrome: A Case Report. Front Endocrinol (Lausanne) 2020;11:557. [PMID: 32903471 DOI: 10.3389/fendo.2020.00557] [Reference Citation Analysis]
5 Yu K, Roncaroli F, Kearney T, Ewins D, Beeharry D, Naylor T, Ray D, Bhalla R, Gnanalingham K. Ectopic Cushing's syndrome secondary to olfactory neuroblastoma. Acta Neurochir (Wien) 2018;160:1023-6. [PMID: 29340776 DOI: 10.1007/s00701-017-3447-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ghazal K, Brabant S, Prie D, Piketty ML. Hormone Immunoassay Interference: A 2021 Update. Ann Lab Med 2022;42:3-23. [PMID: 34374345 DOI: 10.3343/alm.2022.42.1.3] [Reference Citation Analysis]
7 Tardo AM, Reusch CE, Galac S, Fornetti S, Tirolo A, Golinelli S, Shehdula D, Fracassi F. Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases. J Feline Med Surg 2021;23:67-73. [PMID: 32478637 DOI: 10.1177/1098612X20925686] [Reference Citation Analysis]
8 Shi J, Dhaliwal P, Zi Zheng Y, Wong T, Straseski JA, Cervinski MA, Shajani-yi Z, Demarco ML. An Intact ACTH LC-MS/MS Assay as an Arbiter of Clinically Discordant Immunoassay Results. Clinical Chemistry 2019;65:1397-404. [DOI: 10.1373/clinchem.2019.306365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]